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Background: Krüppel-like factors (KLFs) are a group of master regulators of gene expression conserved from flies to
human. However, scant information is available on either the mechanisms or functional impact of the coupling of
KLF proteins to chromatin remodeling machines, a deterministic step in transcriptional regulation.
Results and discussion: In the current study, we use genome-wide analyses of chromatin immunoprecipitation
(ChIP-on-Chip) and Affymetrix-based expression profiling to gain insight into how KLF11, a human transcription
factor involved in tumor suppression and metabolic diseases, works by coupling to three co-factor groups: the
Sin3-histone deacetylase system, WD40-domain containing proteins, and the HP1-histone methyltransferase system.
Our results reveal that KLF11 regulates distinct gene networks involved in metabolism and growth by using single
or combinatorial coupling events.
Conclusion: This study, the first of its type for any KLF protein, reveals that interactions with multiple chromatin
systems are required for the full gene regulatory function of these proteins.
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The traditional strategy for studying the role of transcrip-
tion factors in gene regulation relies on either small or
large-scale expression analysis following overexpression,
somatic knockdown, or germ line deletion. While these
approaches permit the identification of gene networks reg-
ulated by transcription factors, little information is gath-
ered about the chromatin coupling events that ultimately
drive gene expression. This gap in knowledge is unfortu-
nate as transcription factors are often modular proteins
armed with multiple sites for potential interactions with
chromatin cofactors. Thus, knocking-out a transcription
factor will, in theory, disrupt all chromatin-coupling events.* Correspondence: currutia.raul@mayo.edu
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unless otherwise stated.For this reason, it is important to dissect whether different
transcriptional regulators use single or combinatorial coup-
ling events to regulate distinct gene expression networks.
This knowledge is particularly important for proteins
in which dysfunction contributes to disease. Impairment
in each of the coupling events may yield differential effects,
affecting disease penetrance as well as progression. More-
over, with the development of novel chromatin-centric
pharmacology, different drugs can partially inactivate
certain gene networks regulated by a transcription factor
while leaving others intact. Therefore, the dissection of
individual and combinatorial chromatin coupling events
possesses both biological and medical relevance.
Consequently, the current study focuses on KLF11 as a
model system for addressing these important questions.
KLF11 is a well characterized human disease-causing gene
that couples to several chromatin partners [1]. Alterations
in KLF11, originally discovered by its role in growthtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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331 mutation) diabetes [2-4]. KLF11 is an inducible gene,
responsive to a large variety of growth regulatory and
metabolic stimuli, and functions in the nucleus to regulate
gene expression by coupling to distinct chromatin part-
ners. Upon stimuli, KLF11 binds to promoters containing
the consensus CCCCGC/CCCCAC sequences via its three
C-terminal zinc finger domains and, through well-cha-
racterized protein-protein interaction modules in its
N-terminus, differentially recruits chromatin partners
such as the Sin3-HDAC complex [5], WD40 proteins [6],
and the HP1-HMT system [7]. Thus, through these
domains, KLF11 translates environmental signals into
distinct programs of gene expression, which remain to be
defined in detail.
In the current study, we have employed a combination
of genome-wide ChIP-on-Chip and gene expression
profiles to reconstruct both the direct and indirect ef-
fects of KLF11 on the regulation of different gene
networks. Furthermore, we used site-directed mutants to
disrupt individual chromatin coupling domains to gener-
ate genome-wide expression for the identification of the
genes regulated by KLF11 in response to binding to each
of its chromatin cofactors. Our results demonstrate that
certain gene programs require a single chromatin machine
interaction with KLF11 while others require interaction
with multiple chromatin systems. Accordingly, we provide
analyses of the distinct gene networks regulated by KLF11
and its coupling to chromatin partners. This type of
comprehensive genome-wide analysis has never been per-
formed for any member of the KLF family. When applied
to KLF11, our analysis demonstrates that this protein
behaves in a modular fashion with chromatin machinery
to alter gene expression and impacts a variety of biological
processes.
Results
Distinct gene expression networks are regulated by the
differential coupling of KLF11 to individual chromatin
partners
Recent studies support a model whereby KLF11 functions
by binding to GC-rich sites within promoters of different
gene networks involved in the regulation of metabolism
and cell growth [2-4,7-12]. This data is in agreement with
the biological role of this transcription factor in cancer
and diabetes. However, how binding of KLF11 to these
promoters regulates gene expression remains to be fully
understood. Recent data demonstrate that the KLF11 pro-
tein behaves as a scaffold for recruiting different chro-
matin cofactors via distinct structural motifs (Figure 1A).
The Sin3 Interacting Domain (SID) between amino acids
22–40 enables coupling of KLF11 to the Sin3/HDAC
system [11-19]. Introduction of proline residues at amino
acids 29–30 interrupts the association between KLF11and the Sin3 scaffold protein, which includes interactions
with HDAC1/2. The region between 281 and 373 amino
acids is a proline-rich domain that couples with a variety
of WD40 proteins, including G-protein coupled receptors
[4]. The A347S mutation observed in MODY7 (neonatal
diabetes) falls within this domain and has been demon-
strated to decouple KLF11 from novel transcription factor
Gβ2. The zinc finger domain has been demonstrated to
interact with histone acetyltransferases p300 and CBP
[3,20,21]. Finally, the region between 483 and 487 dictates
interaction between KLF11 and HP1α [7]. Deletion of this
C-terminal portion decouples HP1α from histone methyl-
transferases SUV39 and G9a, leading to defects in metab-
olism and tumor suppression. Currently, it is unknown
whether these systems work in isolation or in a coopera-
tive manner to regulate gene expression.
To address this question, we first preformed genome-
wide promoter binding analysis of wild type KLF11. We
then limited our analysis to 5 kb upstream and down-
stream of the transcription start site of known gene pro-
moters. Examination of the distance of KLF11-bound
peaks from each TSS revealed that the majority (~60%)
was within 500–1000 base pairs of the TSS (Figure 1B).
Gene ontological analysis of KLF11-bound targets reveals
association to a large number of metabolic processes,
including many already characterized as regulated by
KLF11, such as insulin regulation [3,4,12] and Akt/TOR
signaling [11] (Figure 1C). Next, we performed genome-
wide expression profiles using mutants for these sites
which have been shown to specifically uncouple KLF11
from each of these chromatin remodeling proteins,
namely EAPP (Sin3/HDAC), A347S (WD40 proteins), and
Δ486 (HP1α/HMT) (Additional file 1: Figure S1). Of the
404 gene targets identified by chromatin immunoprecipi-
tation, for which corresponding gene expression data was
available, 19% (n = 75) display alteration in the presence of
the wild type KLF11 (p < 0.05). Clustering analysis reveals
that the expression pattern of these gene targets is
disrupted in the presence of one or all of the described
mutants. Thus, we conclude that KLF11-mediated gene
expression may be disrupted by decoupling of the tran-
scription factor from its chromatin co-factors in a singular
or combinatorial fashion.
Distinct gene networks are regulated by the
combinatorial coupling of KLF11 to chromatin partners
Next, we investigated which gene targets are uniquely
regulated by each of these pathways. Statistical analyses
of each expression profile show that, indeed, when com-
pared with the empty vector control condition, each muta-
tion induces changes in gene expression that are either
specific to each chromatin system or similar to the wild
type. Thus, comparison of the genes significantly affected
by each condition (p-value <0.05 and fold change ± 1.5)
Figure 1 KLF11-mediated gene expression is disrupted in the presence of chromatin coupling mutations. (A) KLF11 is 495 amino acids
and contains a highly conserved C-terminal C2H2 zinc finger domain. Known chromatin coupling domains explored here are highlighted.
(B) Panc1 epithelial cells were transfected with wild type KLF11 and chromatin immunoprecipitation performed and hybridized to a whole
genome promoter array. The frequency of identified peaks 5 kb upstream and downstream of known transcription start sites were binned
according to distance. The majority of KLF11 binding sites were 500–1000 base pairs from transcription start sites. (C) Gene ontological analysis of
KLF11-bound targets reveals enrichment of genes in known KLF11-associated biological processes, including immune response, TOR signaling,
and insulin sensitivity. For whole genome analysis, mutants were designed against three of the previously characterized chromatin coupling
domains. The EAPP mutation in the N-terminus decouples the Sin3/histone deacetylase system. The A347S mutation in the proline rich domain
decouples KLF11 from WD40 containing proteins. Finally, the deletion mutation starting at amino acid 486 disconnects KLF11 from the HP1/histone
methyltransferase system. Panc1 cells were transduced with empty vector, wild type KLF11 or the A347S, Δ486, or EAPP mutants. Whole genome
transcriptional profiling was performed. The criteria for significant regulation over empty vector was set at a threshold of +/− 1.5 log2 fold change and
a p-value with false discovery rate of less than 0.05. For the EAPP mutant, the p-value did not include false discovery rate thresholding due to the
limited experimental effects of this mutant. (D) 75 genes were significantly regulated by KLF11 overexpression (p < 0.05) and are directly bound by
KLF11 as determined by chromatin immunoprecipitation. Examination of effects of the three chromatin decoupling mutants reveals that expression is
frequently altered in the presence of one or more of these variants.
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wild type KLF11 are also regulated by any of the three
mutations, with the A347S and Δ486 mutations sharing
the largest number of genes with the wild type (Figure 2A).
In fact, of the 801 genes modulated by the Δ486 mutation,
93.9% are also modulated by the A347S mutation. Finally,
the three mutants share with KLF11 only 11 different
genes, which likely require an intact coupling of this tran-
scription factor to all the chromatin proteins involved
in its function (Figure 2B). We observe that the A347S
mutation shows the largest number of significantly regu-
lated transcripts (n = 708) upon the decoupling of KLF11
from WD40 proteins (Figure 3A). By contrast, the subsets
of genes uniquely regulated by the Δ486 or EAPP
mutants are much smaller, 44 and 21 genes, respectively
(Figures 3B-C).
The Δ486 mutation uniquely modulates only 44 genes
(5.5%) of the 801 genes significantly modulated under
expression of the mutant. Almost half of all Δ486 modu-
lated genes (n = 390) are common to the A347S mutantFigure 2 KLF11 differentially couples to distinct chromatin
co-factor systems. (A) Venn diagram of the overlap of genes
significantly regulated by wild type KLF11 and its mutants. Genes
that occur at the overlap of KLF11 and all three of its chromatin-
coupling mutants were deemed as independent of the effects of
chromatin de-coupling and therefore inherent to the protein itself.
(B) Heatmap of the 11 KLF11-regulated genes that are dependent
on interaction with all three chromatin coupling systems.(Figure 3D) and the other half are common to both
A347S and wild type KLF11 (Figure 3E). Interestingly,
the Δ486 and the A347S mutants have, in general, a
similar direction of modulation, although with varying
degrees of signal intensity. On the other hand, the
A347S and Δ486 modulated genes are almost always
completely reverted by the EAPP mutation, in which the
signals are constantly proximal to empty vector values.
Under the same conditions, the A347S mutant, which
associates to the development of human juvenile diabetes,
induces changes in 1521 genes. 46.5% of the modulated
genes (708/1521) are specific to this mutation, while ap-
proximately half of the genes (48%) are common to the
Δ486 mutant and 43.3% are common to both A347S and
wild type KLF11 (352/423, Figure 3F). Finally, 7% of the
genes (n = 50) are common to wild type KLF11, and only
15 common to the EAPP mutant. The EAPP mutation,
which disrupts coupling to the Sin3-HDAC complex,
reverses the expression of most genes induced by the wild
type KLF11 or by the other two mutations.
Identification of KLF11-regulated genes for which expression
is independent of known chromatin coupling events
Subsequently, we examined genes for which expression
might be regulated by KLF11 in a manner that does not
involve the chromatin remodeling machines examined
above. A small percentage of genes are still significantly
modulated uniquely by wild type KLF11 (Figure 3G).
Ontological classification demonstrates that these 14
genes are associated with diabetes (ALMS1P; RAET1L;
GYS1; RBM47; EFR3B), cancer (RPL27A; SPAM1; PTCH1;
ZNF277; USP35; CDC86), or metabolism (C3orf15; AOC2;
GOT1). Taken together, these data indicate that the vast
majority of KLF11’s biological processes are dependent on
its interaction with chromatin regulators within our model
system. A repertoire of chromatin-independent function is
predicted, as the transcription factor is capable of inter-
action with gene promoters directly. Alternatively, the
regulation of these genes may involve yet unidentified
chromatin co-factor.
Pathway reconstruction of combinatorial KLF11-regulated
chromatin pathways by ontological approach
Gene Ontology (GO) enrichment analysis of the genes
modulated by wild type KLF11 and each of the three
mutations show various common biological processes
(Figure 4A). Indeed, the wild type shares 60% (34/57) of
the biological processes with at least one of the mutants.
One of the biological processes, lipid cellular metabolic
process, is enriched in wild type KLF11 and all three
mutants (Additional file 2: Table S1). Among the most
highly enriched biological processes, 14 terms are com-
mon to wild type KLF11 and the A347S and Δ486 muta-
tions. Variations of the intensity of signal, the number of
Figure 3 KLF11 regulates gene expression through combinatorial and singular chromatin coupling events. (A) The A347S mutant, which
decouples KLF11 from WD40 proteins, displays the most genome wide effects, uniquely affecting the expression of 708 genes, whereas the (B)
Δ486 deletion mutation (decouples KLF11 from HP1/histone methyltransferases) and the (C) EAPP mutation (decouples KLF11 from binding the
Sin3 scaffold protein and subsequently histone deacetylases) uniquely regulate only 44 and 21 genes, respectively. (D) Examination of the overlap
between genes significantly regulated by the A347S mutant reveals that approximately 50% are regulated in a similar fashion to the Δ486
mutant, although with varying degrees of intensity. The EAPP mutant, however, displays near complete reversal of these targets. (E) Wild type
KLF11 and the A347S mutant share 411 targets apart from either the EAPP or Δ486 mutants, although (F) 352 targets exists that are shared
between all three systems. These data indicate that KLF11 chromatin coupling occurs in a largely combinatorial fashion. (G) Only 14 genes were
identified that are uniquely regulated by KLF11, independent of chromatin coupling to the transcription factor. Ontological analysis of these
genes reveals roles in cancer, cellular proliferation, and metabolism.
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these 14 biological processes are shown in Additional
file 2: Table S1. Interestingly, wild type KLF11 and
mutants conserve several biological processes related
to anabolism or catabolism of lipids, amino acids, and
glycoconjugates. Other common groups include redox
processes of protein homodimerization, regulation ofthe activity of protein kinases, and response to the
estrogen.
Two of the wild type KLF11 biological processes,
the G2/M transition during DNA damage checkpoint
and cilium assembly, are also conserved in the A347S
mutation. There are 16 biological processes exclusively
conserved between wild type KLF11 and the Δ486 mutant.
Figure 4 Biological regulated by KLF11 and its chromatin binding partners. Genes significantly regulated by wild type KLF11 and its
mutants compared to empty vector were analyzed for enrichment of biological processes by an ontological approach. A threshold of 3 genes
and a p-value of less than 0.05 by Fisher’s Exact Test were required to be considered significantly regulated by the transcription factor and its
mutants. (A) Venn diagram of biological processes demonstrates that the A347S mutant causes the largest number of genome-wide effects with
significant alterations in 150 processes, 93 of which are unique to the mutant. Only one biological process, lipid cellular metabolism, is dependent
on the combinatorial effects of all three chromatin coupling systems. The top biological processes were computed for each of the proteins
compared to empty vector. The pie charts for (B) Wild type KLF11, (C) A347S mutant, (D) Δ486 mutant, and (E) EAPP mutant display the top ten
scoring biological processes for each with enrichment percentage displayed. These results indicate that the effects of KLF11 coupling to chromatin
co-factors impact on a large number of biological functions.
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hyde and nitrogen compound metabolism, isocitrate and
2-oxoglutarate metabolism, glycosaminoglycan catabolic
processes, and fatty acid beta-oxidation.Interestingly, the A347S and Δ486 mutations share
more than a quarter of biological processes (n = 39) that
are absent in wild type KLF11 and the EAPP mutant.
Between these 39 GO terms, we found enrichment of
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tion, RNA polymerase I transcription promoter regulation,
and epigenetic control of gene expression, such as histone
H3 acetylation, chromatin remodeling, protein acetylation
and deacetylation, and regulation of phosphorylation.
Wild type KLF11 and EAPP share only two GO-terms in
common: branched chain amino acid family catabolic
processes and negative regulation of TOR and signaling
cascade.
Overall, 22 of 57 (38.6%) of the biological processes
enriched in the wild type KLF11 are not present any of
the three mutants. Among the 22 most enriched bio-
logical process found only in the wild type KLF11, we
observed several metabolic processes, such as glucose,
carbohydrate, and very long-chain fatty acid metabolism,
oxaloacetate metabolism, fatty acid homeostasis, and
oligosaccharide metabolism. Top processes associated
with wild type KLF11 expression are shown in Figure 4B
and Additional file 3: Table S2. Other specific mechanisms
of wild type KLF11 lost by mutation are two mechanisms
associated with gene expression (transcription from the
RNA polymerase III promoter and mRNA capping) and
two biological processes associated with the integrity of
the DNA (the DNA repair and the response to DNA dam-
age stimulus). Finally, three important biological processes
(e.g., the mitotic cell cycle, the negative regulation of
insulin-like growth factor receptor signaling pathway, and
the negative regulation of epithelial cell proliferation) are
also lost by the mutants. From these data, we conclude
that the combinatorial association between the transcrip-
tion factor and a variety of chromatin coupling systems
dictates the majority of KLF11 function, particularly in
regulating gene expression and metabolism. The high de-
gree of overlap suggests a form of “epigenetic redundancy”
to ensure the proper regulation of these gene targets and
processes.
Pathway reconstruction of singular KLF11-regulated
chromatin pathways by ontological approach
Of the mutants, A347S displays the highest number of
unique biological process that are not enriched in the
wild type (n = 93). Top processes associated with A347S
mutant expression are shown in Figure 4C and Additional
file 3: Table S2. Interestingly, almost 30% of these biological
processes are associated with the structure and mainten-
ance of DNA or telomeres (Additional file 4: Table S3,
List 1), processes related to phosphorylation and dephos-
phorylation, deacetylation, methylation, and demethylation
(Additional file 4: Table S3, List 2), and processes of
transcriptional regulation by poly-II and mRNA transport
(Additional file 4: Table S3, List 3).
In turn, the Δ486 mutant exclusively enriches 45
biological processes that are mediated by the wild type
KLF11 or in other mutants. Top processes associatedwith Δ486 expression are shown in Figure 4C Additional
file 3: Table S2. Unlike the A347S mutant, mutation
Δ486 is particularly enriched in processes associated
with metabolic and biosynthetic processes, protein ex-
port–import, and energy protein modification associated
processes (Additional file 5: Table S4, List 1). Other
groups of processes specifically enriched in this mutant
are associated with proliferation and epithelial cell survival
(Additional file 5: Table S4, List 2).
The EAPP mutant did not display robust gene expres-
sion changes within the experiment. However, utilizing a
more permissive cutoff yields a list of 53 biological cat-
egories, although each only contains a single gene. We
find enrichment of biological processes involving nitric
oxide transport, catabolic processes, and developmental
morphogenesis function, among others. Top processes
associated with EAPP expression are shown in Figure 4E
and Additional file 3: Table S2. From these data, we are
able to identify singular KLF11 chromatin coupling events
dictating a number of critical processes, particularly in
management of cell cycle control and DNA replication,
ones that inherently require a more specific and finely
regulated degree of control to execute their programs
under strict spatial and temporal constraints.
Identification of canonical signaling pathways mediated
by KLF11 and mutants
Subsequently, we wished to further assess the relatedness
between the gene targets significantly modulated by KLF11
and its mutants utilizing a semantic-based approach and
the Ingenuity Global Canonical Pathways (GPC) algorithm.
The input dataset of significantly regulated gene targets
was compared against the IPA canonical pathways, which
are curated from published literature. The significance of
the associations between the data set and a given canonical
pathway is determined by the ratio of the number of genes
mapping to the pathway divided by the total number of
pathway genes. A p-value is calculated using Fischer's
Exact Test determining the probability that the association
between the data set and the pathway occurs by chance
alone. GPC analysis of genes modulated by the wild type
KLF11 and the three mutants shows a variety of signifi-
cantly enriched pathways (p-value <0.05). The wild type
KLF11 shares about 71% (30/42) of its pathways with at
least one of the mutants (Figure 5A). The most important
intersection of common pathways is observed between
wild type KLF11 and mutants A347S and Δ486. Indeed,
90% (38/42) of these pathways are also enriched in at least
one of these two mutants. Only two pathways are shared
between the wild type and the EAPP mutant.
Nevertheless, all genes implicated in these pathways
are differently modulated by wild type KLF11 and each
one of the mutants. The expression of these genes signifi-
cantly regulated by wild type KLF11 and the A347S and
Figure 5 Canonical signaling pathways mediated by KLF11 and mutants. Using the Ingenuity Global Canonical Pathways algorithm,
significantly modulated signaling pathways were identified for wild type KLF11 and its mutants. A p-value of less than 0.05 as determined by
Fisher’s Exact Test was used as criteria for significant association of focus genes to predetermined pathways curated from published literature.
(A) Venn diagram of significant canonical pathways regulated by wild type KLF11 and mutants reveals that the effects of the EAPP mutation are
less significant in this experiment compared to the A347S and 486 mutants. These data are supported by the clustering of all significantly
regulated targets as shown in (B) which demonstrated that the A347S and Δ486 mutants cluster closely with wild type KLF11 while the EAPP
mutant clusters with the empty vector control, indicating complete reversal of the effects of the other proteins. (C) Among the 28 top scoring
unique canonical pathways mediated by the 374 mutant are signaling pathways, including, EGF, PDGR, p53, RANK and reelin signaling, and
glucocorticoid receptor signaling. The Δ486 (D) and EAPP (E) mutants mediate 4 and 6 pathways respectively, both of which are centered on
processes involved on the degradation of biogenic amines. These data support KLF11 as a master transcriptional regulator that mediates large,
interconnected signaling cascades.
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same sense and clustered together (Figure 5B). In
contrast, the EAPP site produces a complete reversion
of the signals with the levels of gene expression close
to the empty vector level, as evidence by its clusteringwith empty vector apart from the wild type KLF11 and
other mutants.
Twelve of the 42 significantly enriched pathways are
conserved only in the wild type KLF11. These normal
functions of the wild type KLF11 are potentially lost by
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pathways includes the nucleotide excision repair path-
way and the alpha-adrenergic signaling pathways. Inter-
estingly, of all the remaining pathways, 80% (9/11) are
metabolic biosynthetic pathways.
Mutant A347S possesses the most exclusive pathways.
Indeed, 28 pathways are enriched in the A347S mu-
tant compared to wild type KLF11 and other mutants
(Figure 5C). Interestingly, over 30% (9/28) of these path-
ways are signaling pathways, including, EGF, PDGR, p53,
RANK and reelin signaling, and glucocorticoid receptor
signaling. Furthermore, pathways involved in diabetes and
pancreatic adenocarcinoma are also present. These path-
ways may explain the massive number of genes differen-
tially modulated by this mutation (n = 1521 genes) and
suggests that this mutant could induce new potentially
unexpected and significant physiopathological changes.
86% of the enriched pathways in the Δ486 mutant are
shared with the wild type KLF11 or the other mutants.
Only four new pathways are specifically enriched by the
Δ486 mutation (Figure 5D). Interestingly, these pathways
are implicated in the degradation of biogenic amines
(an important field associated to physiopathology of
depression and metabolism of drugs of abuse). Finally,
the EAPP mutant influences only six pathways exclusively
(Figure 5E), also primarily related to the degradation
of biogenic amines. Taken together, we conclude that
KLF11 chromatin-coupled gene targets delineate into
specific, well-ordered pathways, consistent with KLF11’s
position as a master transcriptional regulator that me-
diates large cascades of other transcription factors
and regulators. The effects of KLF11 chromatin coup-
ling are therefore not incidental to its function but a
primary means by which to execute gene activation or
repression.
Reconstruction of downstream biological and disease
networks mediated by KLF11 and mutants
We next explored the degree of connectivity between
KLF11 and mutant-regulated genes and their pathobio-
logical associations. Networks of significantly regulated
genes were algorithmically generated based on their
connectivity and assigned a score that encapsulates the
relevance of the generated network to the original list of
focus genes. All edges are supported by at least one
literature reference of direct physical, transcriptional,
and enzymatic interactions, or from canonical informa-
tion stored in the Ingenuity Pathways Knowledge Base.
A right-tailed Fisher’s Exact Test was used to calculate
the p-value for networks and a threshold of p < 0.05 used
to determine significance. A functional analysis of a net-
work then determined the biological functions and/or
diseases that are most significant to the genes contained
within the network (Figure 6).Of the identified processes, only three were common
to wild type KLF11 and all three mutants: cell death and
survival, hereditary disorders, and molecular transport
mechanisms. Wild type KLF11 possessed the most unique
networks (n = 10) and included a number of characterized
biological and disease networks, including cellular growth
and proliferation [22], endocrine disorders, reproductive
system development and function [23], and biliary hy-
perplasia, among others. The A347S mutant uniquely
associates to 6 networks, including ones linked to auditory
disease, cellular compromise, and organismal development.
The Δ486 mutant uniquely associated to 8 networks.
Among the Δ486 mediated networks are significant
associations to gastrointestinal disease, connective tissue
development, and immune presentation and response.
Together, these data recapitulate the repertoire of known
KLF11-mediated functions and uncover a number of new
potential functional and disease associations for future
studies.
Identification of upstream regulators of KLF11-chromatin
coupled pathways
Finally, we wished to identify the upstream transcrip-
tional regulators using Ingenuity’s Upstream Regulator
(UR) analysis. The UR analytic is based on prior know-
ledge of the expected effects of transcriptional regulators
and their target genes stored in the Ingenuity Public
Knowledge Base. The algorithm examines how many
known targets of each transcriptional regulator are present
in the list of significantly regulated targets and compares
direction of expression to that expected from previously
published data. For each potential regulator, an overlap
p-value using Fisher’s Exact Test and an activation z-score
was computed, the latter of which determines the activa-
tion state. A threshold p-value of <0.01 and activation
score of +/− 2 was considered significant for our purposes.
The end result was the identification of upstream regula-
tors of KLF11 or its mutants that permit the generation of
plausible signaling cascades mediated by these upstream
regulators through KLF11 chromatin coupling.
The results of the UR analysis are presented in
Additional file 6: Table S5. Wild type KLF11 displayed
two significant upstream inhibitory regulators, PPARG
and HNF1A, both of which have previously been impli-
cated in the regulation of the transcription factor or as a
co-regulator (Figure 7A) [24]. The A347S mutant, con-
sistent with the gene level, pathway, and network analyses,
is the most disruptive, possessing 9 activating upstream
regulators and 23 inhibitory upstream regulators. Interest-
ingly, EZH2, a histone methyltransferases, is identified as
potential upstream activator. Previous reports have identi-
fied an antagonistic relationship between KLF10 and the
functions of EZH2/Polycomb Repressive Complex [21].
This data hints to other important chromatin couplings to
Figure 6 Biological disease networks mediated by KLF11 and its mutants. Using Ingenuity’s network analysis tool, significantly regulated
genes by KLF11 (A) and its A347S (B) and Δ486 (C) mutants were examined for connectivity. Networks were scored by relevance and a p-value
assigned by Fisher’s Exact Test to discriminate networks generated by chance alone. A threshold of p < 0.05 was employed to determine signifi-
cant networks. Networks were then assessed for association to known biological or disease processes. Wild type KLF11 and its mutants share three
processes: death and survival, hereditary disorders, and molecular transport. Of the identified processes, 10 are unique to wild type KLF11 and 6 and 8 are
unique to the A347S and Δ486 mutants, respectively. A number of known KLF11-mediated biological and diseases processes were revealed by this analysis,
providing an internal control, including endocrine disorders, gastrointestinal disorders, and cellular growth and proliferation processes. However, the analysis
also generated a number of novel biological and disease processes that remain to be experimentally validated for KLF11.
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shows the genes affected in the presence of the mutant
when 486 is inhibited by SREBF1 or JUN and ATF4. For
the 486 mutant, 6 upstream activators were identified and
15 upstream inhibitors, including SREBF2 and HIF1A
(Figure 7C). Although the EAPP did not display anysignificant upstream regulators as defined by our full
criteria, a number of other KLF proteins (KLF1, 3, 7, 13)
were identified as upstream regulators by p-value alone,
suggesting that inter-association of KLF proteins is also
critical to KLF11 function. In addition, we find that KLF10
is identified as affected downstream of both the 486 and
Figure 7 Upstream regulators of KLF11 and its mutants. Gene targets significantly regulated by KLF11 and its mutants were analyzed by
Ingenuity’s Upstream Regulator Analytic that compares the experimentally derive activation or inhibition of focus molecules to relationships
between upstream regulators and target molecules known from published data. For each potential upstream regulator and its targets, a p-value
for the degree of overlap between that of the protein under study and a z-score for the activation status are calculated. For our study, a threshold
of p < 0.05 and a minimum z-score of +/− 2 were employed. The full results are published in Additional file 6: Table S5 and sample signaling
cascades presented for wild type KLF11 (A), A347S (B), and Δ486 (C). No cascades were generated that proved significant for the EAPP mutant
although a more permissive criteria of a p-value of less than 0.05 did generate a number of single gene associations listed in Additional file 6:
Table S5, including a variety of other KLF proteins, hinting at co-regulation within the KLF family. Many of the upstream regulators, such as PPARG,
are previously identified co-regulators of KLF11. While the upstream regulators frequently overlap between wild type and mutant conditions, the
end gene targets are unique to each condition. These results suggest that the deregulation of KLF11 from a large number of gene networks is
completely dependent on the effective coupling of the transcription factor to its chromatin co-factor system.
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tors. Together, these data suggest that transregulation
among KLF proteins is critical to their function and reveal
the potential for a chromatin-dependent interplay between
family members, permitting additional specificity in the
regulation of distinct nodes within their targeted gene ex-
pression networks. Although a number of the regulators
are common to the wild type KLF11 and the A347S and
Δ486 mutants, indicating that mutation does not neces-
sarily impair upstream regulation or co-regulation, the ac-
tivation or inhibition of these proteins regulates a distinct
subset of endpoint genes. The absence of wild type KLF11
targets and acquisition of new, inappropriate targets in the
presence of mutation places KLF11 chromatin coupling
events at the center of the transcription factor’s function
or dysfunction.
In summary, here we have identified the precise inter-
play between KLF11 and three of its chromatin coupling
systems, namely Sin3/HDAC, HP1/HMTs, and WD40
proteins, on a genome-wide scale. The functional repertoire
of KLF11 appears to be dictated by both combinatorial
effects between these systems and singular chromatin coup-
ling events. Redundancy, particularly in critical biologicalprocesses such as metabolism and organismal develop-
ment, occurs between systems to ensure preservation of
critical functions. On the other hand, singular chromatin
coupling events exist to ensure precision in processes
requiring strict spatial and temporal parameters to avoid
inappropriate signaling.
Discussion
Until recently, the relationship between chromatin and
transcription factors appeared largely passive. However,
the evidence that overexpression of four transcription
factors—Oct4, Sox2, m-Myc, and KLF4—is sufficient to
reprogram fully differentiated fibroblasts into pluripotent
ES-like cells suggests an active role for transcription
factors in the epigenetic regulation of chromatin state
[25]. KLF proteins, in particular, have demonstrated a
multitude of feed-forward effects on epigenetic regulation
of gene expression. Here, we propose KLF11 as a model
for understanding the critical role of sequence-specific
factors in epigenetic regulation of a multitude of pathobio-
logical processes.
KLF proteins deliver epigenetic information to gene
promoters through three primary mechanisms: (i) sensing
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gene expression, (ii) sequence-specific targeting of chro-
matin remodeling complexes to gene promoters, and (iii)
transactivation of other transcription factors to assist in
the regulation of large networks of interdependent genes.
Transient regulation of gene expression occurs through
association with histone acetyltransferases (HATs) and
histone deacetyltransferases (HDACs), while long-term
gene silencing is enacted by interactions with histone
methyltransferases (HMTs) and DNA methyltransferases
(DNMTs). No single classification scheme may accurately
characterize the function of KLF11 in its entirety. How-
ever, the classification of family members by virtue of its
co-factors provides a framework to understand the func-
tional differences in the manner in which it engages chro-
matin to activate or repress transcription in a dynamic
and reversible manner.
The association between KLF11 and chromatin coupling
is well established. Initial biochemical characterization of
KLF11 revealed that its N-terminus possesses a domain
that adopts an α-helical conformation and that mutations
within this domain significantly disrupted its binding to
Sin3 and the subsequent recruitment of HDACs [26,27].
Subsequently, KLF11 was found to associate with HP1α
[7], one of the epigenetic “gatekeepers” of gene silencing
through its extreme C-terminus [28-30]. HP1 proteins
repress gene expression by binding to H3K9me marks and
interacting to H3K9 histone methyltransferases, such as
G9a or SUV39H1, which methylate this same residue on
adjacent nucleosomes [31,32]. Deletion of the C-terminus
leads to deregulation of tumor suppression functions
mediated by KLF11. Finally, KLF11 has also been demon-
strated to associate with WD40, WWI, WWII, and
SH3-domain containing proteins through a proline-
rich domain [4]. Interaction of KLF11 and WD40 protein
Gβ2, for example, is disrupted in the presence of the
A347S mutation, the variant associated with development
of Maturity Onset Diabetes of the Young 7 (MODY7).
The effect of decoupling of KLF11 to chromatin co-
factors, however, has only been studied on small subsets
of genes related to the system of focus.
The investigation presented here is the first to attempt
to dissect the roles of KLF11 and chromatin coupling on
a genome-wide level to ascertain the combinatorial or
unique effects of each type of previously identified inter-
acting chromatin system. Utilizing a single cell type with
overexpression of wild type KLF11 and the three previ-
ously described mutants, A347S, Δ486, and EAPP, we
were able to examine the interplay between coupling of
the transcription factor to the WD40, HP1/HMT, and
Sin3/HDAC systems, respectively. By introducing saturat-
ing amounts of each mutant into pancreatic epithelial cells,
we were able to tease apart the relative and overlapping
contributions of each chromatin coupling mechanism tothe regulation of pathobiological gene networks. Our
results reveal that in the pancreatic epithelial cell utilized
as our model, a large number of the affected genes,
networks, and signaling cascades are modulated by the
coupling of KLF11 to its variety of chromatin systems. The
number of genes identified as regulated independently of
these systems represented <1% of the total genes mediated
in the presence of wild type or mutant proteins.
It is important to underscore that the study reported
here is unique as it uses genome-wide approaches to dis-
sect the function of several different chromatin-based
pathways in the transcriptional function of a single KLF
protein. The KLF family of transcription factors consists
of 17 members [1]. Sequence identity at the carboxyl
terminus among KLF family members is greater than >65%,
suggesting the regulation of similar types of gene promoters
and the potential for synergistic or antagonistic regulation
by family members. Despite the high degree of sequence
identity in their DNA-binding ability, the functional activ-
ities of KLF members differ widely due to the high degree
of variability within the N-terminal domain of each pro-
tein, the region responsible for interaction with chromatin
machinery. Although the highly conserved DNA-binding
domain denotes their familial origins, the ultimate func-
tional identity of each KLF protein rests in its their ability
to couple to the molecular machinery that regulate gene
expression, in particular to bind writers, readers, and
erasers of the histone code. Although some family mem-
bers bind to the same chromatin partners as KLF11 [33],
the degree to which the gene networks and biological
processes identified here may be generalized to other
family members remains to be elucidated. However, it is
tempting to speculate that the most closely related pro-
teins KLF9, KLF10, KLF11, KLF13, KLF14, and KLF16
being extensively studied in our laboratory because of
their participation in metabolic processes, may at least
regulate some overlapping gene networks. These proteins
contain distinct motifs which couple to similar and also
distinct chromatin remodeling complexes. In fact, it has
been shown that these proteins couple to the same
chromatin regulators in organisms ranging from flies
to human. Notably, disruption of the KLF11 orthologous
fly gene Cabut, leads to metabolic problems [34]. In
human, alterations in KLF11 causes neonatal and juvenile
Diabetes while its closely related gene, KLF14 causes
obesity and adult type II diabetes [35]. Interestingly, this
function of KLF14 appears to be influenced by a cross
regulation with KLF13. This is interesting since our
microarray data shows that, KLF9 is significantly down-
regulated by wild type KLF11 and KLF10 is upregulated
by the 486 and A347S mutants. Therefore, this data sug-
gests that this subgroup of highly related subfamily of pro-
teins, which appears to have evolved from the fly ancestor
Cabut, share similar chromatin coupling mechanisms,
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extent, share targeted gene networks However, they still
have some degree of biochemical differences as well as
phenotypic outcomes. On the other hand, the rest of the
KLF proteins, which are structurally and functionally less
related to KLF11 but may still share some chromatin part-
ners, are predicted to have fewer overlapping co-regulated
gene networks. In this regard, we are optimistic that the
type of investigations reported here will fuel the interest of
both basic biologists and translational scientists who are
keen on better understanding the function of this exten-
ded family of transcription factor proteins as it relates to
biochemistry, genetics, epigenetics, general biology and
the pathobiology of human diseases.
Conclusion
More than fifteen years ago, our research team hypothe-
sized that the discovery and study of KLF proteins and
their chromatin cofactors would assist in unraveling
complex human diseases. In the intervening years, our
understanding of the interplay between KLF proteins and
epigenetic machinery in transient and long-term gene
regulation has grown exponentially. With knowledge in-
ferred from the predictive power of rationally derived
computational models, we propose a new paradigm for
KLF regulation of gene networks through the translation
of input from cellular milieu into epigenetic information
to affect changes in chromatin structure. KLF proteins
currently provide the best model for understanding the
interactions between mechanisms of “hard inheritance”
(environmental and genetic variation) and “soft inherit-
ance” (epigenetic variation) in underscoring the phenotypic
variability observed in complex disease mechanisms. Per-
haps most importantly, these new pathways open up infin-
ite possibilities for targeting new molecules and processes
in therapeutic intervention and disease management.
Methods
Cell culture
Panc1 cell lines were obtained from the American Type
Culture Collection (ATCC, Rockville, MD). Cells were
cultured as described previously [4,36].
Constructs
Standard molecular biology techniques were used to
clone full length KLF11, KLF11-A347S, KLF11-EAPP,
and KLF11-486 into pcDNA3.1/His (Invitrogen, Carlsbad,
CA). All constructs were verified by sequencing at the
Mayo Clinic Molecular Biology Core Facility. Epitope-
tagged (6XHis-Xpress™) KLF11, KLF11-A347S, KLF11-
EAPP, KLF11Δ486 variants as well as empty vector
(Ad5CMV) were generated as recombinant adenovirus in
collaboration with the Gene Transfer Vector Core at the
University of Iowa.Genome-wide expression profiles of KLF11 and mutants
Panc1 epithelial cells were plated at a density of 1×106
cells/100 mm dish and transduced with empty vector,
KLF11, KLF11-A347S, KLF11-Δ486, or KLF11-EAPP at
an MOI of 150. Relative expression levels were con-
firmed by Western Blot (Additional file 1: Figure S1).
RNA was prepared as previously described from pooled
biological triplicates [37]. Global gene expression profil-
ing was carried out in technical duplicate at the Micro-
arrays Facility of the Research Center of Laval University
CRCHUL utilizing the Affymetrix Human Gene 1.0 ST
arrays (28,869 well-annotated genes and 764,885 distinct
probes). Intensity files were generated by Affymetrix
GCS 3000 7G and the Gene-Chip Operating Software
(Affymetrix, Santa Clara, CA). A subset of genes was
validated by qPCR as previously described (Additional
file 7: Figure S2) [20,38].
Genome-wide promoter binding profile of KLF11
Panc1 epithelial cells were transfected with full-length
His-tagged KLF11. ChIP was performed as previously
described [38-41] using an antibody against the His-Tag
(OMNI D8; Santa Cruz Biotechnology) to detect recom-
binant expression of KLF11. Non-specific IgG antibody
was utilized as a negative control. Binding activity was
derived using the NimbleGen human promoter hybridi-
zation system (Madison, WI). Peaks were detected by
searching for >4 probes where signals were above the
specified cutoff values (90% to 15%) using a 500 bp sliding
window along 5 kb upstream and downstream of the tran-
scriptional start site in human promoters. Each peak was
assigned a score that is the log2 ratio of the fourth highest
probe in each peak. If multiple peaks are present, the peak
nearest the TSS is reported. Ratio data was then random-
ized 20 times to evaluate the false discovery rate (FDR).
Only peaks with FDR scores <0.2 were deemed high confi-
dence binding sites and reported.
Data analysis
Data analysis, background subtraction and intensity
normalization was performed using Robust Multiarray
Analysis (RMA) [42]. Genes that were differentially ex-
pressed along with false discovery rate (FDR) were
estimated from t test (>0.005) and corrected using Bayes
approach [43,44]. A threshold of +/− 1.5 log2 fold change
with a p-value with FDR of less than 0.05 (without FDR
for EAPP mutant) was used to determine significantly
regulated targets. Data analysis, hierarchical clustering,
and ontology were performed with the OneChanelGUI to
extend affylmGUI graphical interface capabilities and
Partek Genomics Suite, version 6.6 (Partek Inc., St. Louis,
MO) with ANOVA and GO ontological analysis [45].
Selected probes and their fold changes were loaded into
Ingenuity Pathways Analysis Software (Ingenuity® Systems,
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canonical pathway, biological network, and upstream
regulator analysis using default parameters.
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